Martin Marietta Appoints New Member to Board of Directors
July 15 2019 - 4:40PM
Martin Marietta Materials, Inc. (NYSE:MLM) today announced the
appointment of Thomas (Tom) H. Pike as an independent member to its
Board of Directors, effective July 15, 2019. With Mr. Pike’s
appointment, the Martin Marietta Board is comprised of 10
directors, five of whom have joined since 2016. Mr. Pike will serve
on Martin Marietta’s Management Development and Compensation
Committee.
Mr. Pike served as Chief Executive Officer and a
member of the Board of Directors of Quintiles Transnational
Holdings, Inc. (“Quintiles”) from April 2016 until its merger in
December 2016 with IMS Health, now known as IQVIA (NYSE:IQV).
Before its merger with IMS, Quintiles had a network of more than
35,000 employees conducting business in approximately 100
countries. Mr. Pike led Quintiles through a successful public
offering and helped it grow into a Fortune 500 company. Under Mr.
Pike’s leadership, Quintiles was named one of the world’s Most
Ethical Companies in 2016. Prior to Quintiles, Mr. Pike spent 22
years at Accenture (NYSE: ACN), a leading global professional
services company, providing a broad range of services and solutions
in strategy, consulting, digital, technology and operations, until
December 2009. At Accenture, Mr. Pike’s roles included serving as
Chief Risk Officer and Managing Director of the North America
Health and Products business areas. He previously served as the
global Chief Operating Officer for Accenture’s Resources operating
group and had also served as Accenture’s Chief Strategy Officer.
Since leaving Accenture in December 2009 and until joining
Quintiles in April 2012, Mr. Pike was involved with a number of
start-ups in the technology and healthcare sectors. Early in his
career, Mr. Pike was a consultant at McKinsey & Company.
Ward Nye, Chairman and Chief Executive Officer,
stated, “We are excited to welcome Tom to Martin Marietta’s Board
of Directors. Tom brings significant experience in global M&A,
strategic, operational, technology and risk management leadership
to the Martin Marietta Board from his role as CEO and a member of
the Board of Directors of Quintiles, a Fortune 500 company before
its merger with IMS Health. In addition, Tom is familiar with both
Colorado and North Carolina, key states in Martin Marietta’s
business. We believe this further strengthens our Board, ensuring
that we have the right mix of skills and experience to continue
building on Martin Marietta’s long track record of success. We are
confident that Tom will make an important and positive impact on
our company.”
About Thomas Pike
Mr. Pike, 59, was named by the AACSB, the global
accrediting body and membership association for business schools,
as one of the first 100 AACSB Influential Leaders. Tom serves on
the Advisory Council for the Schaeffer Center, a leading school of
public health at University of Southern California. He also serves
on the board of a small business services company and operates a
real estate development company. Mr. Pike earned his bachelor of
science in accounting at the University of Delaware.
About Martin Marietta
Martin Marietta, a member of the S&P 500
Index, is an American-based company and a leading supplier of
building materials, including aggregates, cement, ready mixed
concrete and asphalt. Through a network of operations spanning 27
states, Canada and The Bahamas, dedicated Martin Marietta teams
supply the resources necessary for building the solid foundations
on which our communities thrive. Martin Marietta’s Magnesia
Specialties business provides a full range of magnesium oxide,
magnesium hydroxide and dolomitic lime products. For more
information, visit www.martinmarietta.com or
www.magnesiaspecialties.com.
Investor Contact:Suzanne OsbergVice President,
Investor Relations(919)
783-4691Suzanne.Osberg@martinmarietta.com
Accenture (NYSE:ACN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Accenture (NYSE:ACN)
Historical Stock Chart
From Sep 2023 to Sep 2024